These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29666117)

  • 21. Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level.
    Chung C
    J Oncol Pharm Pract; 2020 Jun; 26(4):943-966. PubMed ID: 31964218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent Progress in the Understanding of Angioimmunoblastic T-cell Lymphoma.
    Fujisawa M; Chiba S; Sakata-Yanagimoto M
    J Clin Exp Hematop; 2017; 57(3):109-119. PubMed ID: 29279549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. c-kit Expression and mutations in peripheral T cell lymphomas, except for extra-nodal NK/T cell lymphomas.
    Choe YS; Kim JG; Sohn SK; Kim DH; Baek JH; Lee KB; Do YR; Kwon KY; Song HS; Lee MH; Park TI
    Leuk Lymphoma; 2006 Feb; 47(2):267-70. PubMed ID: 16321856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathology and biology of peripheral T-cell lymphomas.
    de Leval L; Gaulard P
    Histopathology; 2011 Jan; 58(1):49-68. PubMed ID: 21261683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathobiology and molecular profiling of peripheral T-cell lymphomas.
    de Leval L; Gaulard P
    Hematology Am Soc Hematol Educ Program; 2008; ():272-9. PubMed ID: 19074096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular abnormalities in lymphomas].
    Delsol G
    Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New insights in the pathogenesis of T-cell lymphomas.
    Lemonnier F; Gaulard P; de Leval L
    Curr Opin Oncol; 2018 Sep; 30(5):277-284. PubMed ID: 30028743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted based therapy in nodal T-cell lymphomas.
    Chihara D; Miljkovic M; Iyer SP; Vega F
    Leukemia; 2021 Apr; 35(4):956-967. PubMed ID: 33664464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RHOA G17V mutation in angioimmunoblastic T-cell lymphoma: A potential biomarker for cytological assessment.
    Lee PH; Weng SW; Liu TT; You HL; Liao CK; Wang MC; Huang WT
    Exp Mol Pathol; 2019 Oct; 110():104294. PubMed ID: 31394087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular insights into pathogenesis and targeted therapy of peripheral T cell lymphoma.
    Xie C; Li X; Zeng H; Qian W
    Exp Hematol Oncol; 2020 Nov; 9(1):30. PubMed ID: 33292562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary CNS T-cell Lymphomas: A Clinical, Morphologic, Immunophenotypic, and Molecular Analysis.
    Menon MP; Nicolae A; Meeker H; Raffeld M; Xi L; Jegalian AG; Miller DC; Pittaluga S; Jaffe ES
    Am J Surg Pathol; 2015 Dec; 39(12):1719-1729. PubMed ID: 26379152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathology of peripheral T-cell lymphomas: where do we stand?
    Gaulard P; de Leval L
    Semin Hematol; 2014 Jan; 51(1):5-16. PubMed ID: 24468311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations.
    Petit B; Leroy K; Kanavaros P; Boulland ML; Druet-Cabanac M; Haioun C; Bordessoule D; Gaulard P
    Hum Pathol; 2001 Feb; 32(2):196-204. PubMed ID: 11230707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
    Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
    J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma.
    Yoo HY; Kim P; Kim WS; Lee SH; Kim S; Kang SY; Jang HY; Lee JE; Kim J; Kim SJ; Ko YH; Lee S
    Haematologica; 2016 Jun; 101(6):757-63. PubMed ID: 26819049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.
    Vallois D; Dobay MP; Morin RD; Lemonnier F; Missiaglia E; Juilland M; Iwaszkiewicz J; Fataccioli V; Bisig B; Roberti A; Grewal J; Bruneau J; Fabiani B; Martin A; Bonnet C; Michielin O; Jais JP; Figeac M; Bernard OA; Delorenzi M; Haioun C; Tournilhac O; Thome M; Gascoyne RD; Gaulard P; de Leval L
    Blood; 2016 Sep; 128(11):1490-502. PubMed ID: 27369867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features.
    Ondrejka SL; Grzywacz B; Bodo J; Makishima H; Polprasert C; Said JW; Przychodzen B; Maciejewski JP; Hsi ED
    Am J Surg Pathol; 2016 Mar; 40(3):335-41. PubMed ID: 26574844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral T-cell lymphomas.
    Macon WR
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):829-42. PubMed ID: 19577171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New biomarkers in T-cell lymphomas.
    Bisig B; Gaulard P; de Leval L
    Best Pract Res Clin Haematol; 2012 Mar; 25(1):13-28. PubMed ID: 22409820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice-PART 2: ENKTL, EATL, Indolent T-Cell LDP of the GI Tract, ATLL, and Hepatosplenic T-Cell Lymphoma.
    Zing NPC; Fischer T; Zain J; Federico M; Rosen ST
    Oncology (Williston Park); 2018 Aug; 32(8):e83-e89. PubMed ID: 30153323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.